Role of Bile Acid Pathway Intermediates in Pathology of CTX (2023)
Attributed to:
Lipidomics and metabolomics for rare disease diagnosis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.5281/zenodo.10050199
Publication URI: https://zenodo.org/doi/10.5281/zenodo.10050199
Type: Preprint